The Day In Review: Biotech Climbs Following Fed Hike
10/19/2005 5:12:28 PM
December 14, 2004 -- The Centient Biotech 200™ gained 14.40 to 3528.79, a .40% rise. That was ahead of the NYSE Composite, which added on .31%, and just behind the Nasdaq, which was higher by .53%. We discuss the news about Abbott Labs, Merck, Forest Labs, Xoma and Corixa.